Fundz

Sirnaomics Secures $105 Million In Series E Financing

PRIVATEJul 01, 2021

Amount Raised

$105 Million

Round Type

Series E

GaithersburgBiotechnology

Description

Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it has sealed $105 million in a Series E financing. This round of funding was led by Rotating Boulder Fund, an investor that has been supporting the company since its Series B round, with participation from existing investors and a well-recognized syndicate of new investors.

Quick answer

Sirnaomics, Inc. raised $105 Million in a Series E round, dated July 1, 2021. Sirnaomics, Inc. is based in Gaithersburg, Maryland, United States.

How much did Sirnaomics, Inc. raise?
Sirnaomics, Inc. raised $105 Million in a Series E round on July 1, 2021.
What does Sirnaomics, Inc. do?
Sirnaomics is an RNA therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of innovative drugs for indications with medical needs..
Where is Sirnaomics, Inc. based and how big is it?
Sirnaomics, Inc. is based in Gaithersburg, Maryland, United States.
Who are the decision-makers at Sirnaomics, Inc?
Fundz holds 1 contact at Sirnaomics, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Sirnaomics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Cernostics, Inc. raised $6M on August 13, 2021.
  • Namida Lab, Inc. raised $5M on August 13, 2021.
  • Polaris Quantum Biotech, Inc. raised $2.9M (Seed) on August 12, 2021.
  • CytoAgents raised $6.1M on August 12, 2021.
  • Praesidia Biotherapeutics raised $7.4M (Seed) on August 12, 2021.
  • Syntr Health Technologies raised $2.2M (Seed) on August 12, 2021.

Who to call at Sirnaomics, Inc., and when

A new round usually means Sirnaomics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Sirnaomics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Sirnaomics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Sirnaomics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Sirnaomics, Inc.

Location

401 PROFESSIONAL DRISUITE 280

Gaithersburg, Maryland, United States

About

Sirnaomics is an RNA therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of innovative drugs for indications with medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both China and the United States, and also the first company to achieve positive Phase IIa clinical outcomes in oncology for an RNAi therapeutic for its core product, STP705. Learn more at www.sirnaomics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Sirnaomics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts50 people are listed at Sirnaomics, Inc.. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Sirnaomics, Inc.'s next move

See what Strategic adds

Sirnaomics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.